Historial de carrera de Pierre V. Verroye
Antiguos cargos conocidos de Pierre V. Verroye.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| Boehringer Mannheim Corp. (California) | Corporate Officer/Principal | 01/01/1998 | 01/01/1998 |
Human Genome Sciences, Inc.
 Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | Director Técnico/Científico/I+D | 11/06/2012 | - |
Formación de Pierre V. Verroye.
| Université Catholique de Lille | Undergraduate Degree |
Estadísticas
Internacional
| Estados Unidos | 3 |
| Francia | 2 |
Operativa
| Chief Tech/Sci/R&D Officer | 1 |
| Corporate Officer/Principal | 1 |
| Undergraduate Degree | 1 |
Sectorial
| Health Technology | 2 |
| Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas privadas | 2 |
|---|---|
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | Health Technology |
| Boehringer Mannheim Corp. (California) |
- Bolsa de valores
- Insiders
- Pierre V. Verroye
- Experiencia
